SCHEMBL6345973

SCHEMBL6345973

COc1ccc2cc(-n3cc(N4C(=O)C=CC4=O)c4ccccc43)ccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 3/20 0.45
HSP90AA1 P07900 1/20 0.43
PTGS2 P35354 1/20 0.42
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 3/20 0.41
MAPT P10636 3/20 0.41
HTT P42858 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TP53 P04637 2/20 0.40
G6PD P11413 1/20 0.40
TLR9 Q9NR96 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2A6 P11509 1/20 0.39
LMNA P02545 2/20 0.38
MAOB P27338 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849912 0.87 HSP90AA1 (0.58) MGLLHSP90AA1ALDH1A1TLR9SMN1; SMN2
SCHEMBL6355781 0.83 HSP90AA1 (0.46) MGLLHSP90AA1TLR9CYP1A2NPSR1
SCHEMBL6345530 0.76 MGLL (0.50) MGLLHSP90AA1KDM4EALDH1A1HTT
SCHEMBL6344199 0.69 TLR9 (0.40) MGLLKDM4EALDH1A1MEN1KMT2A
SCHEMBL4845035 0.69 PRKCB (0.45) MGLLALDH1A1MAPTHTTHSD17B10
SCHEMBL6348067 0.69 TLR9 (0.40) MGLLKDM4EALDH1A1TLR9
SCHEMBL6344247 0.68 MGLL (0.44) MGLLHSP90AA1ALDH1A1HTTMEN1
SCHEMBL6354137 0.67 ALDH1A1 (0.41) HSP90AA1KDM4EALDH1A1SMN1; SMN2
SCHEMBL6404071 0.67 CYP1A2 (0.62) MGLLHSP90AA1KDM4EALDH1A1HTT
SCHEMBL5688433 0.67 TLR9 (0.50) MGLLALDH1A1MAPTKMT2ATLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6849643-B2 Indazolyl-substituted pyrroline compounds as kinase inhibitors ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2005-02-01 US disclosed